Fertility
Endometriosis: What employers need to know

With around 1 in 10 women affected by endometriosis, providing fertility support can improve wellbeing, productivity, and retention.
Q&A with Natasha Fernando, GP & Medical Director, Medichecks
In an increasingly diverse workplace, understanding and supporting the health challenges faced by employees is crucial. One condition that remains under the radar for many businesses is endometriosis, a condition that affects one in ten women.
Dr Natasha Fernando, a practicing GP and Medical Director at Medichecks, offers her insights on the importance of supporting employees with endometriosis and how businesses can create a culture of understanding and care.
Q: Why is it important for employers to support employees with endometriosis?
Endometriosis affects around 1 in 10 women of reproductive age (approximately 176 million women globally), and it can have a significant impact on both physical and emotional health. It often causes chronic pain, fatigue, and can interfere with a person’s ability to focus and perform well at work.
Without the right support, employees may struggle to balance their health and work commitments.
According to a study by Endometriosis UK, 50 per cent of women with endometriosis report needing to take time off work due to the condition, and in February this year, national research for England proved that sufferers earn less as a result.
By fostering a culture that acknowledges the challenges of endometriosis, businesses can reduce stress, improve retention, and create a more inclusive environment. Employees who feel supported during difficult times are more likely to stay engaged and loyal to their employer.
Q: How can businesses create a supportive environment for employees with endometriosis?
A strong workplace strategy should focus on flexibility, understanding, and providing access to healthcare. Flexible working hours or remote working can make a huge difference to employees dealing with pain or fatigue. Employers can also help by offering time off for medical appointments or flare-ups.
Another crucial aspect is creating an open environment where employees feel comfortable discussing their condition without fear of stigma. Raising awareness is key, as only 27 per cent of women with endometriosis feel their employers understand their condition (Endometriosis UK).
Training leadership to recognise the signs of endometriosis and offering mental health support, such as access to counselling or Employee Assistance Programmes (EAPs), are also vital steps.
Q: What should a workplace health strategy include for employees with endometriosis?
The strategy should focus on flexibility, access to relevant health services, and raising awareness. Employers can offer practical support like adjusted hours, remote working options, or additional leave for medical appointments. There should also be a focus on educating staff and managers about endometriosis, as awareness and understanding can significantly reduce stigma and improve workplace culture.
Offering access to diagnostic services or health checks can also be a helpful step, allowing employees to manage their condition more proactively. With studies showing that 1 in 3 women with endometriosis experience difficulty managing their condition at work, an informed strategy is essential (NHS England).
Q: How does endometriosis affect productivity, and what can businesses do to mitigate this?
Endometriosis can have a substantial impact on productivity, particularly during flare-ups. Employees might experience debilitating pain, fatigue, heavy periods (which can cause anemia and fatigue) or other symptoms that affect their ability to concentrate and meet deadlines. Around 6.5 million workdays are lost every year in the UK due to endometriosis (Endometriosis UK).
To mitigate this, employers should consider offering flexible working options and a supportive work environment. Acknowledging that this is a long-term condition for many employees, and offering proactive support, such as adjusted workloads during flare-ups, can help employees manage their symptoms and continue working effectively.
Q: Is fertility support necessary for employees with endometriosis?
Fertility issues are common among those with endometriosis, with studies showing that 30 to 50 per cent of women with the condition experience infertility (Endometriosis UK). Offering support in this area can be important. However, the condition itself can affect many aspects of a person’s health and wellbeing, so fertility support should be just one part of a broader approach.
Businesses that provide access to fertility treatments, flexible working, and other health resources can show that they care about the whole person, not just their ability to perform at work. Proactively offering support before fertility becomes a concern can make a significant difference.
Q: What would you say to businesses that feel endometriosis support is outside their remit?
Supporting employees with endometriosis doesn’t require a major overhaul of business practices—it can be as simple as showing empathy and making small adjustments that demonstrate understanding. Providing flexibility, raising awareness, and offering access to healthcare resources are all effective ways to support employees without straining business resources.
A compassionate, inclusive approach can help improve morale, reduce absenteeism, and foster loyalty. In turn, this can contribute to a more positive and productive work environment.
Dr. Natasha Fernando – Medical Director, Medichecks
Dr Natasha Fernando is the Medical Director at Medichecks, where she leads a team of doctors and healthcare professionals dedicated to offering accessible, evidence-based health testing. With over 12 years of experience in the NHS, Dr Fernando also practices as a GP and holds a Diploma in Lifestyle Medicine. Passionate about preventative healthcare, she works to ensure individuals have access to the tools and knowledge needed to make informed decisions about their health.
Cancer
AI could transform ovarian care through personalisation, study finds

AI could transform ovarian care by personalising cancer and fertility treatment, but more clinical validation is needed before routine use.
A systematic review and meta-analysis found AI models showed high diagnostic accuracy for ovarian cancer when combining data such as ultrasound scans and blood test results.
Across 81 studies, AI models correctly identified ovarian cancer in around nine out of 10 cases, with pooled rates of 89 to 94 per cent.
They were also highly accurate at ruling out ovarian cancer when it was not present, with specificity of 85 to 91 per cent.
The analysis also found that explainable AI tools could predict complete surgical cytoreduction in advanced ovarian cancer.
Complete surgical cytoreduction means removing all visible cancer during surgery, which can be an important goal in treatment planning.
The tools achieved a pooled AUC of 0.87. AUC is a measure of how well a model distinguishes between different outcomes, with higher scores showing stronger performance.
In reproductive medicine, AI algorithms helped physicians optimise ovarian stimulation protocols and predict follicular growth during IVF.
Ovarian stimulation is the use of hormones to encourage the ovaries to produce eggs, while follicles are the small sacs in the ovaries where eggs develop.
The review found AI could reliably model ovarian response in IVF with a pooled AUC of 0.81.
However, researchers said challenges remain in translating promising research findings into routine clinical practice.
They identified substantial variation across studies, driven by retrospective study designs, variable AI systems and a lack of standardised validation.
Only 22 per cent of analysed studies reported prospective, multicentre external validation, where models are tested forward in time across multiple healthcare settings.
The authors called for rigorous validation to help close the gap between research and routine clinical practice, alongside standardised methodological and reporting frameworks, smooth integration with clinical workflow and robust governance to support responsible and ethical AI use.
They concluded: “Artificial intelligence is a transformative force in the management of ovarian conditions.
“In gynaecologic oncology, AI enhances every phase of care, from early detection and accurate diagnosis to prognostic stratification and surgical planning.”
In reproductive medicine, AI personalises ovarian stimulation and refines the diagnosis of heterogenous endocrine disorders such as PCOS.
PCOS, or polycystic ovary syndrome, is a hormonal condition that can affect periods, skin, weight and fertility.
Fertility
Housing, work and fertility stop Britons having the families they want – research
Fertility
Femtech World reveals fertility innovation award shortlist

Femtech World is thrilled to reveal the shortlist for the Fertility Innovation Award.
The award, sponsored by FinDBest IVF, celebrates a pioneering product, service or initiative that is transforming fertility care and support.
FinDBest IVF is a global B2B digital platform created to simplify and accelerate how IVF and ART manufacturers connect with trusted, pre-vetted distributors around the world.
This year’s nominees represent a remarkable breadth of approaches to fertility care: from clinic-floor breakthroughs to at-home hormone intelligence to truly borderless access.
Three companies made the cut, with each tackling a real, persistent barrier in reproductive health.
Congratulations to the shortlist and many thanks to everyone who entered.
Fertility Innovation Award Shortlist

HRC Fertility’s Needle-Free IVF is a pioneering advancement designed to transform one of the most challenging aspects of fertility treatment: daily hormone injections.
Developed by board-certified reproductive endocrinologist Dr Rachel Mandelbaum, this innovative approach reimagines how stimulation medications are delivered during IVF and egg freezing, dramatically improving the patient experience while maintaining the same trusted clinical outcomes.
Inspired by feedback from patients who struggled with the injection process, Dr Mandelbaum adapted an innovative drug-delivery system commonly used in other areas of medicine and applied it to reproductive care

Mira is a hormonal health technology company that provides lab-grade hormone testing and AI-driven insights to help women and couples understand their fertility.
The platform has already supported more than 200,000 couples on their fertility journeys worldwide, helping over 60,000+ users achieve pregnancy.
For some users, pregnancy rates have reached up to 89 per cent within six months, demonstrating how accurate hormone data can significantly improve fertility outcomes.

Founded in 2021 by Marija Skujina, a Certified Fertility Nurse Specialist accredited by the European Society of Human Reproduction and Embryology, with nearly 15 years of clinical experience at one of the world’s top IVF clinics, and having navigated her own fertility journey as a patient, Marija built the clinic she had always wished existed.
Plan Your Baby began with a bold, but simple mission – make best quality fertility and pregnancy available anywhere.
Plan Your Baby has created a new generation fertility and pregnancy clinic with patients accessing expert consultations remotely, while blood tests and ultrasound scans are available at over 450 locations across the UK, eliminating the exhausting travel burden that often forces people to take days off work, relocate appointments, or abandon treatment altogether
What happens now
The shortlist will be judged by a representative from category sponsor FindBestIVF, with the winner announced at a virtual event on June 19.
Winners will receive a trophy and be interviewed by a Femtech World journalist.
Entrepreneur4 weeks agoWomen’s digital health market set to reach US$5.28 billion in 2026 – report
Insight4 weeks agoWhy the UK’s fertility rate keeps falling – and what it means if you’re trying now
Wellness4 weeks agoWomen’s HealthX unveils Northwell Health, Corewell Health, Biogen & more to headline Chronic Disease stage
Mental health3 weeks agoWhat Maternal Mental Health Month reveals about where postpartum support actually breaks down
Fertility4 weeks agoToxins and climate harms having ‘alarming’ effect on fertility, research warns
News3 weeks agoNIH Grant terminations disproportionately impact minority scientists, research finds
Adolescent health2 weeks agoWUKA brings Period-Positive Pool Party to London Aquatics Centre to keep girls swimming through puberty
Fertility4 weeks agoResearcher explores weight loss jab impact on PCOS














